help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolon, I.
Right arrow Articles by Brambilla, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolon, I.
Right arrow Articles by Brambilla, E.

American Journal of Pathology, Vol 150, 1619-1629, Copyright © 1997 by American Society for Investigative Pathology


REGULAR ARTICLES

Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas

I Bolon, M Devouassoux, C Robert, D Moro, C Brambilla and E Brambilla
Lung Cancer Research Group, Institut A. Bonniot, La Tronche, France.

We have previously shown that the extracellular-matrix-degrading enzymes, urokinase-type plasminogen activator (u-PA), stromelysin 1, stromelysin 3, and matrilysin, may play an important role in the transition from lung preneoplasia to invasive carcinoma. Using in situ hybridization and immunohistochemistry, we analyzed serial frozen sections for the expression of these enzymes in 89 lung carcinomas including 25 neuroendocrine (NE) carcinomas (10 small-cell lung carcinomas, 7 large-cell NE carcinomas, 1 atypical, and 7 typical carcinoids) and 64 non-small-cell, non-NE carcinomas (29 squamous and 7 basaloid carcinomas, 23 adenocarcinomas, and 5 large-cell carcinomas). Proteases, except matrilysin, were more often expressed in stromal than cancer cells. In non-small-cell, non-NE carcinomas, stromal co- expression of u-PA and stromelysin 3 was seen in 80 to 90% of the tumors and was highly correlated (P < 0.0001). Stromal u-PA and stromelysin 3 expression was linked to tumor size (P = 0.01 and 0.03, respectively) and lymph node involvement (P = 0.001 and 0.02, respectively). Epithelial expression of u-PA was correlated to tumor size (P = 0.04). Epithelial expression of stromelysin 3 predominated in squamous and basaloid carcinomas (P = 0.0005) and was inversely correlated to squamous differentiation (P = 0.018). Epithelial expression of matrilysin predominated in adenocarcinomas and large-cell carcinomas (P = 0.07). In NE carcinomas including small-cell lung carcinomas, stromal expression of u-PA was correlated to lymph node metastasis (P = 0.017). Epithelial expression of all enzymes were significantly less frequent in NE than in non-NE tumors. We conclude that 1) epithelial expression of matrix proteases in lung cancer is linked to cell phenotype (NE versus non-NE, squamous versus glandular) and 2) their stromal, rather than epithelial, expression influences local metastasis.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Y. Miyata, T. Iwata, K. Ohba, S. Kanda, M. Nishikido, and H. Kanetake
Expression of Matrix Metalloproteinase-7 on Cancer Cells and Tissue Endothelial Cells in Renal Cell Carcinoma: Prognostic Implications and Clinical Significance for Invasion and Metastasis
Clin. Cancer Res., December 1, 2006; 12(23): 6998 - 7003.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Ii, H. Yamamoto, Y. Adachi, Y. Maruyama, and Y. Shinomura
Role of Matrix Metalloproteinase-7 (Matrilysin) in Human Cancer Invasion, Apoptosis, Growth, and Angiogenesis
Experimental Biology and Medicine, January 1, 2006; 231(1): 20 - 27.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. S. Rao, C. Gondi, C. Chetty, S. Chittivelu, P. A. Joseph, and S. S. Lakka
Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells
Mol. Cancer Ther., September 1, 2005; 4(9): 1399 - 1408.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Arora, J. Kaur, C. Sharma, M. Mathur, S. Bahadur, N. K. Shukla, S. V.S. Deo, and R. Ralhan
Stromelysin 3, Ets-1, and Vascular Endothelial Growth Factor Expression in Oral Precancerous and Cancerous Lesions: Correlation with Microvessel Density, Progression, and Prognosis
Clin. Cancer Res., March 15, 2005; 11(6): 2272 - 2284.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Sriuranpong, A. Mutirangura, J. W. Gillespie, V. Patel, P. Amornphimoltham, A. A. Molinolo, V. Kerekhanjanarong, S. Supanakorn, P. Supiyaphun, S. Rangdaeng, et al.
Global Gene Expression Profile of Nasopharyngeal Carcinoma by Laser Capture Microdissection and Complementary DNA Microarrays
Clin. Cancer Res., August 1, 2004; 10(15): 4944 - 4958.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Pedersen, S. Mortensen, S. B. Sorensen, M. W. Pedersen, K. Rieneck, L. F. Bovin, and H. S. Poulsen
Transcriptional Gene Expression Profiling of Small Cell Lung Cancer Cells
Cancer Res., April 15, 2003; 63(8): 1943 - 1953.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. R. Nelson, B. Fingleton, M. L. Rothenberg, and L. M. Matrisian
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
J. Clin. Oncol., March 1, 2000; 18(5): 1135 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. J. Delebecq, H. Porte, F. Zerimech, M.-C. Copin, V. Gouyer, E. Dacquembronne, M. Balduyck, A. Wurtz, and G. Huet
Overexpression Level of Stromelysin 3 Is Related to the Lymph Node Involvement in Non-small Cell Lung Cancer
Clin. Cancer Res., March 1, 2000; 6(3): 1086 - 1092.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
K. Yamashita, M. Mori, T. Shiraishi, K. Shibuta, and K. Sugimachi
Clinical Significance of Matrix Metalloproteinase-7 Expression in Esophageal Carcinoma
Clin. Cancer Res., March 1, 2000; 6(3): 1169 - 1174.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. M. Adam, J. G. Borer, B. J. Williams, J. A. Eastham, K. R. Loughlin, and M. R. Freeman
Amphiregulin Is Coordinately Expressed with Heparin-Binding Epidermal Growth Factor-Like Growth Factor in the Interstitial Smooth Muscle of the Human Prostate
Endocrinology, December 1, 1999; 140(12): 5866 - 5875.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
C. Robert, I. Bolon, S. Gazzeri, S. Veyrenc, C. Brambilla, and E. Brambilla
Expression of Plasminogen Activator Inhibitors 1 and 2 in Lung Cancer and Their Role in Tumor Progression
Clin. Cancer Res., August 1, 1999; 5(8): 2094 - 2102.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G Cox, W P Steward, and K J O'Byrne
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer
Thorax, February 1, 1999; 54(2): 169 - 179.
[Full Text]


Home page
Am. J. Pathol.Home page
H. Kataoka, H. Uchino, T. Iwamura, M. Seiki, K. Nabeshima, and M. Koono
Enhanced Tumor Growth and Invasiveness in Vivo by a Carboxyl-Terminal Fragment of {alpha}1-Proteinase Inhibitor Generated by Matrix Metalloproteinases : A Possible Modulatory Role in Natural Killer Cytotoxicity
Am. J. Pathol., February 1, 1999; 154(2): 457 - 468.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.